Expertise in
7
conditions

Martin Laimer

Salzburg, AT 
Expertise in
7
conditions
Salzburg, AT 

Overview

Martin Laimer practices practicing medicine in Salzburg, Austria.

Mr. Laimer is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Epidermolysis Bullosa, Dystrophic Epidermolysis Bullosa, Dominant Dystrophic Epidermolysis Bullosa, and Dowling-Meara Epidermolysis Bullosa Simplex.

He is actively involved in clinical research, co-authoring 100 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Salzburg, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow-up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa
Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow-up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa
Enrollment Status: Completed
Publish Date: July 20, 2023
Intervention Type: Drug
Study Drug: Oleogel-S10
Study Phase: Phase 3
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Enrollment Status: Terminated
Publish Date: November 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

100 Total Publications

Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma.
Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma.
Journal: Science advances
Published: June 24, 2026

Frequently Asked Questions about Martin Laimer

Is Martin Laimer a top-rated expert for Epidermolysis Bullosa?

MediFind is an objective health platform that identifies experts based on real-world data. Martin Laimer is classified as an Elite expert for Epidermolysis Bullosa, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Martin Laimer participate in research or clinical trials?

Yes. Martin Laimer has published 100 articles and abstracts on conditions like Epidermolysis Bullosa. You can view a list of Martin Laimer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Laimer's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile